GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

elosulfase alfa   Click here for help

GtoPdb Ligand ID: 7392

Synonyms: BMN 110 | rhGALNS | Vimizim®
Approved drug
elosulfase alfa is an approved drug (EMA & FDA (2014))
Compound class: Peptide
Comment: Elosulfase alfa is a recombinant enzyme replacement therapy for galactosamine (N-acetyl)-6-sulfatase (GALNS, P34059) deficiency. The peptide is translated from the human cDNA expressed in CHO cells [1].
Classification Click here for help
Compound class Peptide
Approved drug? Yes. EU EMA (2014)  |  US FDA (2014)
International Nonproprietary Names Click here for help
INN number INN
9686 elosulfase alfa
Synonyms Click here for help
BMN 110 | rhGALNS | Vimizim®
Database Links Click here for help
CAS Registry No. 9025-60-9 (source: SciFinder)
GtoPdb PubChem SID 178103964
Search PubMed clinical trials elosulfase alfa
Search PubMed titles elosulfase alfa
Search PubMed titles/abstracts elosulfase alfa
Wikipedia Elosulfase_alfa